Renishaw's first neuromate® frameless Gen II stereotactic robotic system in the U.S. has been installed at the Hospital in Philadelphia. Ashwini D. Sharan, MD, Professor and Director of the neurosurgery department of the Thomas Jefferson University Sidney Kimmel Medical College Department of Neurological Surgery, and his colleague Dr. Chengyuan Wu, Consulting Neurosurgeon, have performed the first case using the robotic system for a Stereo-EEG implantation case in epilepsy.
"The newly acquired neuromate system will provide me and my team with a platform for a broad range of stereotactic neurosurgical procedures," said Dr. Sharan. "We are pleased to have a neuromate at our center, as we believe this is only the beginning of an exciting future for robotics in the neurosurgery operating room."
"This installation confirms the trust of a leading US neurosurgical center in the neuromate system and in Renishaw," added Dr. Abed Hammoud, CEO of Renishaw Mayfield SA. "Our clinical and technical support teams will work closely with the neurosurgery team at Thomas Jefferson University Hospital, to ensure the seamless integration of the neuromate into their surgical workflow, thus aiding them to provide optimal outcomes for their patients."
Renishaw is a global company with core skills in measurement, motion control, spectroscopy, neurosurgical products and precision machining. The company has 3,800 employees based at offices in 32 countries, and is listed on the London Stock Exchange (LSE:RSW) where it is a constituent of the FTSE 250. For more information visit www.renishaw.com
Inquiries should be directed to:
In USA: Susan Wilm, Marketing Assistant, Renishaw Inc., 5277 Trillium Blvd., Hoffman Estates, IL 60192. email@example.com Tel: 847-286-9953
In Canada: Dafydd Williams, General Manager, Renishaw (Canada) Limited, 2180 Dunwin Drive, Unit #1, Mississauga ONT L5L 5M8. firstname.lastname@example.org Tel: 905-828-0104